To investigate whether the high expression of NB CRC components impacts CASZ1 expression, we first analyzed publicly available CRC TFs ChIP-seq data of noradrenergic NB cell lines BE(2)C and SY5Y [10, 39]. The gene discussed is CASZ1; the disease is colorectal carcinoma.